Skip to main content
Back to Menlo Ventures

Menlo Ventures's Therapeutics Portfolio

Browse 11 Therapeutics companies funded by Menlo Ventures. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
11
Total Funding in Therapeutics
$1.7B

Therapeutics Portfolio Companies (11)

Export
Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Salt Lake City, United States
June 2024
$200.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Alameda, United States
June 2026
$25.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

H1 is on a mission to connect the world to the right doctor

New York, United States
May 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

South San Francisco, United States
May 2026
$10.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareTherapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

South San Francisco, United States
April 2024
$1.0B
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalMental HealthmHealthTherapeutics

Grow Therapy offers online therapy services that connects individuals with licensed therapists to support mental health.

New York, United States
March 2026
$150.0M
Series D

Founder Contacts

30,000+ verified contacts

Health CareMental HealthmHealthTherapeuticsWellness

Cartwheel offers mental health support to students in order to help schools regain balance in the midst of the student mental health crisis.

Cambridge, United States
August 2025
$35.2M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsPharmaceuticalRecruitingTherapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

South San Francisco, United States
January 2023
$287.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareHealth InsuranceHome Health CarePharmaceuticalTherapeutics

Ophelia offers medication and support for quitting opioids.

New York, United States
December 2021
Series B

Founder Contacts

30,000+ verified contacts

Health CareOncologyTherapeutics

Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.

Epalinges, Switzerland
November 2022
$38.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareTherapeutics

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

South San Francisco, United States
March 2021
Series D

Founder Contacts

30,000+ verified contacts

Explore Menlo Ventures's Full Portfolio

View all companies funded by Menlo Ventures across every industry and funding stage.

View Full Menlo Ventures Portfolio